stockrow
Friday 6 November 2026
Export FOCL’s income statement to Excel — free account
FocalTherics
FOCL Healthcare Medical Distribution
- Revenue
- +38.9%
- EPS
- −129.4%
- Free cash flow
- +21.5%
- Total debt
- +366.8%
Quarter to June 2026, against a year earlier
3.66
0.59
−13.88%
Follow FOCL
Alert me
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
20.88 | 0.00 | 0.00 | 84.70 | 0.00 | 247.52 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
6 | 1 | 5 | 8 | 2 | 5 | 3 | 3 | 4 | 3 |
Altman Z-Score |
2.51 | 2.07 | 1.29 | 3.20 | 3.01 | 4.15 | 7.72 | 2.77 | (0.10) | (0.87) |
P/S ratio |
2.36 | 2.05 | 1.16 | 2.56 | 3.17 | 3.69 | 6.18 | 3.00 | 1.19 | 1.75 |
P/FCF ratio |
36.53 | 0.00 | 0.00 | 0.00 | 115.12 | 72.97 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
2.08 | 1.45 | 1.42 | 2.08 | 1.45 | 4.33 | 5.37 | 1.66 | (1.90) | (5.40) |
Beneish M-Score |
(2.34) | (1.91) | (2.40) | (2.57) | (2.88) | (2.70) | (2.44) | (2.59) | (2.80) | (3.14) |
P/Operating CF |
75.05 | (23.96) | 259.54 | 30.20 | 33.26 | 61.21 | (51.13) | (41.01) | (1,791.35) | (50.84) |
P/B ratio |
3.43 | 2.91 | 1.82 | 4.20 | 4.69 | 3.38 | 4.70 | 3.19 | 1.94 | 6.35 |
Price to Tangible BV |
3.84 | 3.30 | 2.09 | 4.75 | 5.17 | 3.55 | 4.86 | 3.33 | 2.12 | 7.31 |
EV/Sales |
1.92 | 1.64 | 0.83 | 2.21 | 2.67 | 2.84 | 5.12 | 2.37 | 0.91 | 1.78 |
EV/EBITDA |
175.06 | 0.00 | 0.00 | 69.05 | 415.36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
14.33 | (17.67) | (5.05) | (810.80) | 18.92 | 28.20 | (93.32) | (9.74) | (4.29) | (7.63) |
EV/FCF |
29.78 | (7.76) | (2.96) | (17.71) | 97.13 | 56.22 | (50.43) | (7.40) | (3.15) | (5.40) |
Quick Ratio |
2.13 | 2.00 | 1.95 | 1.91 | 1.72 | 3.30 | 3.60 | 2.27 | 1.33 | 1.16 |
Current Ratio |
2.70 | 2.45 | 2.40 | 2.41 | 2.11 | 3.75 | 4.17 | 2.84 | 1.85 | 1.54 |
Net Debt/EBITDA |
(10.97) | 32.38 | (44.25) | (3.75) | (6.67) | (126.88) | 21.02 | 2.07 | 1.00 | (0.18) |
Debt/Assets |
13.87% | 11.31% | 13.06% | 10.52% | 16.07% | 10.49% | 7.28% | 7.04% | 12.97% | 30.84% |
Debt/Equity |
0.26 | 0.21 | 0.26 | 0.20 | 0.34 | 0.16 | 0.10 | 0.11 | 0.27 | 1.26 |
Asset Turnover |
0.83 | 0.77 | 0.84 | 0.86 | 0.78 | 0.68 | 0.59 | 0.64 | 0.74 | 0.84 |
Operating CF/Net income |
0.29 | 4.49 | (0.52) | 2.51 | (1.16) | 6.35 | 1.03 | 0.69 | 0.71 | 0.56 |
Capex/Depreciation |
(1.15) | (0.98) | (1.16) | (0.77) | (0.94) | (0.86) | (1.45) | (2.25) | (1.60) | (1.69) |
| 19.74% | (2.77%) | (1.38%) | 5.63% | (6.42%) | 1.86% | (4.59%) | (33.44%) | (39.55%) | (94.50%) | |
| 9.01% | (1.47%) | (0.72%) | 2.89% | (3.18%) | 1.07% | (3.12%) | (22.29%) | (21.84%) | (34.73%) | |
ROIC |
2.74% | (12.11%) | (6.92%) | 11.41% | 1.61% | (9.18%) | (16.79%) | (62.22%) | (60.16%) | (66.17%) |
Return on Tangible Assets |
13.59% | (2.51%) | (1.22%) | 5.27% | (6.18%) | 1.32% | (4.02%) | (36.92%) | (49.72%) | (96.15%) |
Average Days of Receivables |
102.77 | 126.03 | 124.06 | 102.29 | 108.09 | 100.38 | 98.97 | 116.21 | 110.86 | 116.87 |
Research and Development Expense of Revenue |
10.86% | 10.86% | 10.43% | 8.30% | 10.79% | 7.72% | 8.93% | 11.52% | 12.05% | 13.70% |
Selling, General and Administrative Expense of Revenue |
34.12% | 36.24% | 36.10% | 33.56% | 32.68% | 37.74% | 42.70% | 61.67% | 61.40% | 63.85% |
Intangible Assets out of Total Assets |
0.06 | 0.06 | 0.07 | 0.06 | 0.06 | 0.04 | 0.03 | 0.04 | 0.04 | 0.06 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 4.31% | 3.82% | 11.36% | 5.12% | 3.63% |
Graham Net Nets |
0.22 | 0.24 | 0.37 | 0.14 | 0.13 | 0.24 | 0.18 | 0.25 | 0.31 | (0.02) |
Graham Number |
1.87 | 0.00 | 0.00 | 1.11 | 0.00 | 0.98 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
4.79% | (1.05%) | (0.88%) | 1.18% | (1.29%) | 0.40% | (0.67%) | (11.86%) | (24.89%) | (23.40%) |
Free Cash Flow Yield |
2.74% | (10.30%) | (24.03%) | (4.89%) | 0.87% | 1.37% | (1.64%) | (10.64%) | (24.24%) | (18.82%) |
Revenue per Share |
1.42 | 1.40 | 1.60 | 1.73 | 1.63 | 1.62 | 1.69 | 1.77 | 1.86 | 1.88 |
Operating CF per Share |
0.04 | (0.12) | 0.01 | 0.15 | 0.08 | 0.16 | (0.09) | (0.43) | (0.39) | (0.44) |
Capex per Share |
(0.05) | (0.06) | (0.08) | (0.06) | (0.08) | (0.06) | (0.07) | (0.13) | (0.12) | (0.15) |
Free Cash Flow per Share |
0.00 | (0.18) | (0.07) | 0.09 | 0.00 | 0.10 | (0.16) | (0.56) | (0.51) | (0.59) |
Cash per Share |
0.87 | 0.78 | 0.79 | 0.81 | 0.97 | 1.74 | 1.93 | 1.27 | 0.83 | 0.55 |
Shareholders Equity per Share |
0.97 | 0.98 | 1.02 | 1.06 | 1.03 | 1.84 | 2.19 | 1.67 | 1.14 | 0.52 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.97 | 0.98 | 1.02 | 1.06 | 1.03 | 1.84 | 2.19 | 1.67 | 1.14 | 0.52 |
Free Cash Flow |
(0.06) | (5.19) | (2.00) | 2.63 | 0.00 | 3.31 | (5.63) | (20.54) | (19.14) | (22.17) |
Working Capital |
28.22 | 26.49 | 27.83 | 27.56 | 27.29 | 58.48 | 72.50 | 55.07 | 33.31 | 20.02 |
Capital Expenditures |
(1.30) | (1.73) | (2.21) | (1.63) | (2.25) | (1.95) | (2.44) | (4.65) | (4.44) | (5.76) |
Net Current Asset Value |
20.33 | 20.16 | 19.60 | 18.35 | 18.79 | 47.57 | 64.30 | 47.46 | 25.67 | (2.42) |
EV/EBIT |
175.06 | 0.00 | 0.00 | 45.19 | 415.36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.03 | 0.04 | 0.05 | 0.03 | 0.05 | 0.04 | 0.04 | 0.07 | 0.06 | 0.08 |
Price to Operating Income |
214.77 | 0.00 | 0.00 | 52.14 | 492.31 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.37 | 0.43 | 0.38 | 0.46 | 0.57 | 0.53 | 0.38 | 0.30 | 0.34 | 0.33 |
Cash ROIC |
(0.11%) | (9.10%) | (3.34%) | 4.36% | 0.01% | 2.66% | (3.76%) | (17.76%) | (22.50%) | (34.51%) |
Accounts Receivable Turnover |
3.26 | 3.23 | 3.12 | 3.37 | 3.38 | 3.67 | 3.86 | 3.58 | 3.31 | 3.23 |
Accounts Payable Turnover |
3.18 | 3.45 | 3.61 | 3.77 | 4.00 | 4.65 | 4.82 | 4.05 | 3.21 | 3.26 |
Inventory Turnover |
2.70 | 2.87 | 3.26 | 3.03 | 2.91 | 3.37 | 3.06 | 2.71 | 2.29 | 2.53 |
Average Days of Payables |
113.30 | 110.00 | 103.23 | 92.30 | 89.48 | 78.46 | 78.48 | 114.50 | 117.63 | 106.12 |
Days of Inventory on Hand |
152.65 | 117.48 | 118.23 | 124.85 | 125.24 | 106.74 | 139.08 | 153.17 | 172.51 | 115.55 |
Average Receivables |
12.08 | 12.52 | 14.84 | 14.91 | 14.10 | 14.22 | 15.04 | 18.28 | 20.95 | 21.83 |
Average Payables |
6.68 | 6.86 | 7.28 | 7.10 | 6.65 | 6.52 | 6.76 | 9.62 | 12.66 | 12.44 |
Average Inventory |
7.86 | 8.25 | 8.07 | 8.84 | 9.14 | 9.00 | 10.64 | 14.38 | 17.78 | 16.02 |
Average Assets |
47.20 | 52.28 | 55.28 | 58.50 | 61.24 | 77.21 | 98.95 | 102.81 | 94.24 | 84.20 |
Average Common Equity |
21.54 | 27.75 | 28.96 | 30.06 | 30.31 | 44.60 | 67.34 | 68.54 | 52.05 | 30.95 |
Columns are period end dates · fundamentals updated 26 Oct 2026